Biostar Pharmaceuticals, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Biostar Pharmaceuticals, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $2.59 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2017-11-20
- 2017-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.59M.
- 2017-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.56M.
- 2017-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.78M.
- 2016-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.78M; Financial and Nonfinancial Liabilities, Fair Value Disclosure as first filed $2.83M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure as first filed |
|---|---|---|
| 2017-09-30 | $2.59M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $2.56M 10-Q · filed 2017-11-15 | |
| 2017-03-31 | $2.78M 10-Q · filed 2017-05-19 | |
| 2016-12-31 | $2.78M 10-Q · filed 2017-11-20 | $2.83M 10-K · filed 2017-04-13 |
| 2016-09-30 | $2.43M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $2.45M 10-Q · filed 2016-08-22 | |
| 2016-03-31 | $2.54M 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $2.78M 10-K · filed 2017-04-13 | $2.83M 10-K · filed 2016-04-14 |
| 2015-09-30 | $2.97M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $3.23M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $3.34M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $3.48M 10-K · filed 2016-04-14 |